UTHR (unither.com) Earnings per share growth this year

Official company branding of United Therapeutics Inc. (UTHR)

United Therapeutics combines strategic xenotransplantation alliances with steady demand for hypertension therapy. The annual change in EPS clearly demonstrates the business's reaction to market challenges, with the indicator reaching -11.60. A commitment to ESG principles is reflected in the construction of energy-efficient, net-zero carbon laboratories.

UTHR (unither.com) Earnings per share growth in current year history from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for unither.com (UTHR)

Basic company analysis:United Therapeutics Inc. (UTHR)
Manufactured products of United Therapeutics

Professional managers utilize earnings per share dynamics to distinguish sustainable businesses from overvalued assets. This indicator measures the annual change in net income, reflecting the ability of United Therapeutics (UTHR) to convert its monopoly in the orphan disease niche into real growth of shareholder equity, as clearly evidenced by the year-over-year EPS growth rates.

Main competitors

Earnings per share growth rate in current year Vertex Pharmaceuticals Inc. (VRTX)|ALNY (Alnylam) - Earnings growth in current year|Earnings per share growth this year INSM (Insmed)|Net earnings per share growth this year BMRN (BioMarin)|BBIO (BridgeBio Pharma) - Earnings per share increase in current year|Earnings growth in current year BGM (BGM Group Ltd)|COGT (Cogent Bio) - Earnings per share trend in current year|Xeris Biopharma - Earnings growth in current year|Earnings per share increase in current year KROS (Keros Therapeutics)|ARCT: Earnings growth in current year|Eton Pharmaceuticals Inc (ETON) - Earnings growth in current year|Earnings per share growth in current year Kamada Corp|FULC: Earnings per share increase in current year|Earnings per share growth in current year Abeona Therapeutics, Inc. (ABEO)|Net earnings per share growth this year Mereo BioPharma Group plc MREO|Earnings per share growth in current year Protalix BioTherapeutics PLX|Earnings growth in current year Pliant Therapeutics PLRX|appliedtherapeutics.com - Earnings growth in current year|Earnings per share increase in current year RNTX (Rein Therapeutics, Inc.)|GELS: Earnings growth in current year|Earnings per share growth rate in current year Aytu BioPharma, Inc. (AYTU)|CMMB (Chemomab Therapeutics Ltd) - Earnings growth in current year|Earnings per share growth this year SRXH (SRx Health Solutions)|Net earnings per share growth this year PLRZ (Polyrizon Ltd)|AEZS - Earnings per share growth rate in current year|Earnings per share growth in current year Cyclo Therapeutics Inc. CYTH|Inozyme Pharma, Inc. (INZY) - Earnings per share growth rate in current year|RPHM: Net earnings per share growth this year|Earnings per share growth rate in current year COSCIENS Biopharma Inc